Genetics study for inherited heart muscle disease
Part of Heart & circulation clinical trials.
This study is looking for people with inherited heart muscle disease that may be genetic. It uses advanced genetic testing to better understand the cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have been diagnosed with cardiomyopathy (heart muscle disease)
- Your cardiomyopathy is suspected to be genetic, not from other causes like high blood pressure or alcohol
- If you had genetic testing before with no answers, you can still join
- A close family member has the same type of cardiomyopathy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic causes of inherited heart (cardiovascular) and muscle/nerve (neuromuscular) conditions. You may be asked about your family history and possibly genetic samples to help connect symptoms to specific genetic changes.
This study looks at people with unusual or rare heart problems, or people with a family history of these issues. Doctors and researchers may collect and study your blood or tissue (and possibly store samples) to learn what causes the condition and how it may affect the heart.
This is an observational study that follows children under 18 with cardiomyopathy caused by certain MYBPC3 gene mutations. It aims to better understand how the disease changes over time, which may help future treatments be better targeted.
This study looks at the genes behind cardiomyopathy (a disease of the heart muscle). It may help explain why it happens in your family and guide better care for you and relatives.
This study looks at genetic (DNA) changes that may cause cardiomyopathy, a disease where the heart muscle is weakened. It may help families understand possible causes and inform future care.
This study looks at people with cardiomyopathy (or related heart muscle conditions) and those who may be at risk because of family history or genetic test results. It may help researchers better understand who is likely to develop the condition and how best to monitor or support them.
Hear when a new Whole Genome Sequencing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.